Australia's Mayne Pharma plunges; no update on potential buyout interest

Mayne Pharma

21/11/2024 03:14

** Shares of Australian drugmaker Mayne Pharma  MYX.AX  fall
as much as 7.7% to A$4.11, their lowest since Aug. 23
    ** Co provides no update on potential buyout interest, at
its annual general meeting
    ** MYX earlier in the month said Jefferies to assist co in
terms of looking for a possible bidder 
    ** Stock posts its biggest intraday pct fall since Nov. 13
    ** Co says total revenue for the July-Oct period came in at
A$132.5 mln ($86.32 mln), lower than the A$137 mln reported in
the previous corresponding period
    ** Two analysts covering the stock rate it "buy" or higher,
their median PT is A$2.0 – LSEG data
    ** Stock had fallen 32.7% this year, as of last close

($1 = 1.5349 Australian dollars)

 (Reporting by Nichiket  Sunil)
 ((Nichiket.Sunil@thomsonreuters.com;))